CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On June 10th, 2024 With 0.81 USD Dividend Per Share
March 28th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on June 10th, 2024. Shareholders of record on June 10th, 2024 will receive 0.81 USD dividend per
CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On March 7th, 2024 With 0.81 USD Dividend Per Share
January 10th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on March 7th, 2024. Shareholders of record on March 8th, 2024 will receive 0.81 USD dividend p
CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On December 7th, 2023 With 0.81 USD Dividend Per Share
September 28th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on December 7th, 2023. Shareholders of record on December 8th, 2023 will receive 0.81 USD di
CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On September 7th, 2023 With 0.81 USD Dividend Per Share
July 1st - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on September 7th, 2023. Shareholders of record on September 8th, 2023 will receive 0.81 USD divide
CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G' To Go Ex-Dividend On June 8th, 2023 With 0.81 USD Dividend Per Share
June 7th - $CONNECTICUT LIGHT & POWER CO 3.24% PRF USD50 SER'G'(CNLPL.US)$ is trading ex-dividend on June 8th, 2023. Shareholders of record on June 9th, 2023 will receive 0.81 USD dividend per sha
CDC expert group supports injection of Pfizer Inc for the elderly and high-risk groups
An advisory panel of experts from the US Centers for Disease Control and Prevention (CDC) voted on Thursday to recommend that the Pfizer Inc / BioNTech COVID-19 epidemic enhancement needle be provided to the elderly in the United States, nursing home residents and other vulnerable groups, clearing the way for the agency to make final approval at night at the earliest. The agency's Advisory Committee on Immunization practice unanimously agreed to provide a third dose of Pfizer Inc COVID-19 vaccine to people aged 65 and above and residents of sanatoriums. The group also recommended intensive injections for adults between the ages of 18 and 64 with underlying diseases and rejected plans to provide a wide range of enhanced needles to the American public. United States Food and Drug Administration (
The number of jobless claims in the US recorded 310,000 at the beginning of the week until September 4
The number of jobless claims in the US recorded 310,000 at the beginning of the week until September 4, 2020, a new low since the week of March 14, 2020. After the initial US jobless claims data was released, the spot gold, silver, and dollar indices DXY did not fluctuate much in the short term. Agencies evaluated the US jobless claims data at the beginning of the week, saying that thanks to the progress of vaccinations and reopening increased demand for workers, the number of initial jobless claims in the US declined steadily. The decline in claims data at the beginning of last week exceeded expectations, indicating that the job market continues to fully recover. However, initial jobless claims are still higher than pre-pandemic levels, and the recent surge in confirmed cases could disrupt the recovery of the job market. Sutra
What is the fund manager's favorite stock right now? It's all in this sheet
While hedge fund managers withdrew from economically sensitive stocks this month, they also began piling up investments in growth stocks. This successful tactic helped them beat the return of the S&P 500. According to Jefferies data, hedge funds actively increased their holdings in growth stocks in July, with an increase rate of 12.8%. This is the rate of increase in holdings in this type of stock since April 2020. Meanwhile, the Wall Street firm said that after being optimistic about cyclical stocks since July last year, the industry has now reduced its risk appetite to reduce its holdings. Jefferies stock strategist Steven DeSanct
No Data